All Cosmos Bio-Tech Holding Corporation
Informe acción TWSE:4148
Capitalización de mercado: NT$3.3b
Salud financiera de hoja de balance de All Cosmos Bio-Tech Holding
Salud financiera controles de criterios 5/6 All Cosmos Bio-Tech Holding tiene un patrimonio de accionistas total de NT$2.9B y una deuda total de NT$555.0M, lo que sitúa su ratio deuda-patrimonio en 19.4%. Sus activos y pasivos totales son NT$3.8B y NT$895.4M respectivamente. El BAIT de All Cosmos Bio-Tech Holding es de NT$154.1M, por lo que su ratio de cobertura de intereses es de -4.3. Tiene efectivo e inversiones a corto plazo que ascienden a NT$1.5B.
Información clave
19.4%
Ratio deuda-patrimonio
Ratio de cobertura de intereses -4.3x Efectivo NT$1.51b Patrimonio NT$2.86b Total pasivo NT$895.38m Activos totales NT$3.75b
Actualizaciones recientes sobre salud financiera
Mostrar todas las actualizaciones
All Cosmos Bio-Tech Holding Corporation to Report Q3, 2024 Results on Nov 12, 2024 Nov 05
Investor sentiment improves as stock rises 16% Oct 30
Second quarter 2024 earnings released: EPS: NT$0.12 (vs NT$0.61 in 2Q 2023) Aug 31
All Cosmos Bio-Tech Holding Corporation to Report Q2, 2024 Results on Aug 27, 2024 Aug 20
Upcoming dividend of NT$1.00 per share Jul 04
First quarter 2024 earnings released: EPS: NT$0.44 (vs NT$0.63 in 1Q 2023) May 19
Dividend of NT$1.00 announced May 15 All Cosmos Bio-Tech Holding Corporation to Report Q1, 2024 Results on May 13, 2024 May 05
New minor risk - Market cap size Apr 15
All Cosmos Bio-Tech Holding Corporation, Annual General Meeting, Jun 21, 2024 Mar 27
There May Be Reason For Hope In All Cosmos Bio-Tech Holding's (TWSE:4148) Disappointing Earnings Mar 22
Full year 2023 earnings released: EPS: NT$2.18 (vs NT$5.75 in FY 2022) Mar 19
All Cosmos Bio-Tech Holding Corporation Announces the Retirement of Ling Siu Hung as Chief Operating Officer Feb 01
Investor sentiment improves as stock rises 17% Dec 11
New minor risk - Earnings quality Nov 30
Third quarter 2023 earnings released: EPS: NT$1.07 (vs NT$2.48 in 3Q 2022) Nov 14
New minor risk - Earnings quality Sep 10
Second quarter 2023 earnings released: EPS: NT$0.61 (vs NT$1.47 in 2Q 2022) Aug 26
New minor risk - Market cap size Aug 11
Upcoming dividend of NT$2.50 per share at 4.1% yield Jul 03
Full year 2022 earnings released: EPS: NT$5.75 (vs NT$3.09 in FY 2021) Mar 28
Investor sentiment improves as stock rises 16% Feb 06
Third quarter 2022 earnings released: EPS: NT$2.48 (vs NT$0.76 in 3Q 2021) Nov 18
High number of new directors Nov 16
Investor sentiment deteriorated over the past week Oct 13
Investor sentiment deteriorated over the past week Sep 28
Second quarter 2022 earnings released: EPS: NT$1.47 (vs NT$0.66 in 2Q 2021) Sep 01
High number of new directors Aug 01
Investor sentiment improved over the past week Jul 25
Investor sentiment improved over the past week Jul 08
High number of new directors Jul 01 All Cosmos Bio-Tech Holding Corporation Announces Change in Remuneration Committee All Cosmos Bio-Tech Holding Corporation Approves Cash Dividends for 2021
Upcoming dividend of NT$1.50 per share Jun 16
First quarter 2022 earnings released: EPS: NT$1.07 (vs NT$0.42 in 1Q 2021) May 14
Investor sentiment deteriorated over the past week May 10
Price target increased to NT$102 Apr 27
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Apr 08
Full year 2021 earnings released: EPS: NT$3.09 (vs NT$1.28 in FY 2020) Mar 30
Investor sentiment improved over the past week Mar 14
Investor sentiment improved over the past week Feb 24
Third quarter 2021 earnings released: EPS NT$0.76 (vs NT$0.54 in 3Q 2020) Nov 12
Investor sentiment improved over the past week Oct 05
Second quarter 2021 earnings released: EPS NT$0.66 (vs NT$0.60 in 2Q 2020) Aug 31
Upcoming dividend of NT$1.00 per share Jun 29
First quarter 2021 earnings released: EPS NT$0.42 (vs NT$0.41 loss in 1Q 2020) May 14
All Cosmos Bio-Tech Holding Corporation Announces Cash Dividend, Payable on July 30, 2021 May 12
Is All Cosmos Bio-Tech Holding (TPE:4148) Using Too Much Debt? Apr 20
Price target decreased to NT$40.00 Apr 20
Acting for the Malaysian Subsidiary All Cosmos Bio-Tech Holding Corporation to Announce Temporary Shutdown of the Production Department Jan 22
Returns On Capital At All Cosmos Bio-Tech Holding (TPE:4148) Paint An Interesting Picture Jan 10
New 90-day high: NT$39.40 Jan 07
All Cosmos Bio-Tech Holding Corporation's (TPE:4148) Price Is Out Of Tune With Earnings Dec 22
Are Poor Financial Prospects Dragging Down All Cosmos Bio-Tech Holding Corporation (TPE:4148 Stock? Dec 01
Third quarter 2020 earnings released: EPS NT$0.54 Nov 13
New 90-day low: NT$33.80 Oct 29
First half earnings released Aug 14
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (NT$2.8B) de 4148 superan a sus pasivos a corto plazo (NT$837.7M).
Pasivo a largo plazo: Los activos a corto plazo de 4148 (NT$2.8B) superan a sus pasivos a largo plazo (NT$57.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 4148 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 4148 ha crecido de 6.9% a 19.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de 4148 está bien cubierta por el flujo de caja operativo (89.5%).
Cobertura de intereses: 4148 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.
Descubre empresas con salud financiera Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
